CNMD
$40.09
Revenue | $337.93Mn |
Net Profits | $2.86Mn |
Net Profit Margins | 0.85% |
Conmed Corp’s revenue jumped 6.7% since last year same period to $337.93Mn in the Q3 2025. On a quarterly growth basis, Conmed Corp has generated -1.29% fall in its revenue since last 3-months.
Conmed Corp’s net profit fell -94.16% since last year same period to $2.86Mn in the Q3 2025. On a quarterly growth basis, Conmed Corp has generated -86.65% fall in its net profits since last 3-months.
Conmed Corp’s net profit margin fell -94.53% since last year same period to 0.85% in the Q3 2025. On a quarterly growth basis, Conmed Corp has generated -86.48% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 1.05 |
EPS Estimate Current Year | 1.05 |
Conmed Corp’s earning per share (EPS) estimates for the current quarter stand at 1.05 - a 10.53% jump from last quarter’s estimates.
Conmed Corp’s earning per share (EPS) estimates for the current year stand at 1.05.
Earning Per Share (EPS) | 0 |
Dividend Per Share (DPS) | 0.2 |
Conmed Corp’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Conmed Corp has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Conmed Corp declared 0.2 dividend per share during the earnings announcement for Q3 2025.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-07-31 | 0.95 | 0.69 | -27.37% |
2025-05-01 | 0.81 | 0.95 | 17.28% |
2025-11-06 | 1.05 | 0 | -100% |